Pacira BioSciences, Inc. (PCRX) — Tangible Net Worth Ratio
Pacira BioSciences, Inc. (PCRX) has a Tangible Net Worth Ratio of 46.0% as of March 2026. This metric is calculated by deducting intangible assets ($353.23 Million) from net assets ($653.89 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Pacira BioSciences, Inc. (PCRX) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Pacira BioSciences, Inc. Tangible Net Worth Ratio (2008–2025)
This chart shows how Pacira BioSciences, Inc.'s Tangible Net Worth Ratio has changed across 16 annual periods from 2008 to 2025. As of March 2026, the ratio stands at 46.0%, reflecting net assets of $653.89 Million with intangible assets of $353.23 Million USD. See Pacira BioSciences, Inc. defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Pacira BioSciences, Inc. (2008–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Pacira BioSciences, Inc. from 2008 to 2025, covering 16 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Pacira BioSciences, Inc. market capitalisation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 46.9% | $693.11 Million | $368.10 Million | $1.26 Billion | ▲ +1.6 pp |
| 2024 | 45.3% | $778.35 Million | $425.97 Million | $1.55 Billion | ▲ +0.8 pp |
| 2023 | 44.5% | $870.13 Million | $483.26 Million | $1.57 Billion | ▲ +14.2 pp |
| 2022 | 30.3% | $775.01 Million | $540.55 Million | $1.68 Billion | ▲ +15.7 pp |
| 2021 | 14.6% | $730.41 Million | $623.97 Million | $2.08 Billion | ▼ -69.9 pp |
| 2020 | 84.4% | $619.69 Million | $96.52 Million | $1.27 Billion | ▲ +13.8 pp |
| 2019 | 70.6% | $354.94 Million | $104.39 Million | $831.07 Million | ▼ -29.4 pp |
| 2018 | 100.0% | $321.23 Million | $0.00 | $689.35 Million | ▲ +19.7 pp |
| 2017 | 80.3% | $279.48 Million | $55.20 Million | $628.37 Million | ▲ +1.6 pp |
| 2016 | 78.7% | $218.98 Million | $46.74 Million | $391.47 Million | ▼ -21.3 pp |
| 2015 | 100.0% | $218.39 Million | $81.00K | $389.62 Million | ▲ +0.2 pp |
| 2014 | 99.8% | $171.15 Million | $403.00K | $326.07 Million | ▲ +2.6 pp |
| 2013 | 97.2% | $41.25 Million | $1.16 Million | $169.82 Million | ▲ +2.1 pp |
| 2012 | 95.1% | $65.86 Million | $3.21 Million | $112.05 Million | ▲ +6.0 pp |
| 2011 | 89.1% | $48.27 Million | $5.26 Million | $113.49 Million | ▲ +163.8 pp |
| 2008 | -74.7% | $7.49 Million | $13.08 Million | $50.54 Million | — |